Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8026
Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinoma of the Penis
Activated
09-15-1980
Closed
08-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8066
Adjuvant Intrahepatic Chemotherapy with Mitomycin-C and 5-FU Combined with Hepatic Radiation in High Risk Patients with Carcinoma of the Colon
Activated
08-25-1980
Closed
03-03-1983
Closed
Phase
SWOG Clinical Trial Number
SWOG-8015
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8012
Treatment for Advanced Adenocarcinoma and Large Cell Carcinoma of the Lung: FOMi vs CAP vs FOMi/CAP
Activated
08-04-1980
Closed
12-23-1982
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8006
Preoperative Reductive Chemotherapy for Stage III or IV Operable Epidermoid Carcinoma of the Oral Cavity, Oropharynx, Hypopharynx or Larynx
Research Committee(s)
Head and Neck Cancer
Activated
07-14-1980
Closed
02-20-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8001
Evaluation of Two Maintenance Regimens in the Treatment of Acute Lymphoblastic Leukemia in Adults
Activated
07-10-1980
Closed
03-22-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7984
The Treatment of Chronic Stage CML with Pulse, Intermittent Busulfan Therapy with or without Oral Vitamin A
Activated
07-10-1980
Closed
04-01-1987
Closed
Phase
SWOG Clinical Trial Number
SWOG-8014
Colchicine in Refractory Chronic Lymphocytic Leukemia
Activated
07-07-1980
Closed
10-23-1981
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8017
5-FU, Adriamycin, Streptozotocin and Cyclophosphamide (FAC-S) in the Treatment of Metastatic Carcinoid Tumors
Activated
07-07-1980
Closed
01-19-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8004
Evaluation of DHAD in Soft Tissue and Bone Sarcomas
Activated
07-03-1980
Closed
07-28-1981
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8009
Evaluation of Diydroxythracenedione (DHAD) in Patients with Refractory Small Cell Lung Cancer
Activated
07-03-1980
Closed
05-11-1982
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8065
DHAD in Adults with Metastatic Malignant Melanoma
Activated
07-02-1980
Closed
10-18-1983
Closed
Phase
SWOG Clinical Trial Number
SWOG-8008
Evaluation of Dihydroxyanthracenedione (DHAD) in Refractory Breast Cancer
Activated
07-02-1980
Closed
09-10-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-8010
Evaluation of Dihydroxyanthracenedione (DHAD) in Advanced Prostate Cancer
Activated
07-02-1980
Closed
12-28-1981
Closed
Phase
SWOG Clinical Trial Number
SWOG-8005
Evaluation of Dihydroxyanthracenedione (DHAD) in Refractory Malignant Lymphomas
Research Committee(s)
Lymphoma
Activated
07-02-1980
Closed
05-10-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-8011
Evaluation of Dihydroxyanthracenedione (DHAD) in Patients with Advanced Renal Cell Carcinoma
Activated
07-02-1980
Closed
04-14-1981
Closed
Phase
SWOG Clinical Trial Number
SWOG-8063
Evaluation of Anguidine (NSC-141537) in Refractory Adult Acute Nonlymphocytic Leukemia
Activated
04-22-1980
Closed
04-14-1981
Closed
Phase
SWOG Clinical Trial Number
SWOG-7985
Combined Modality Treatment for ER - Breast Cancer
Activated
03-03-1980
Closed
09-10-1982
Closed
Phase
SWOG Clinical Trial Number
SWOG-7940/41
Evaluation of MGBG in Metastatic Adenocarcinoma of the Large Bowel
Activated
02-27-1980
Closed
09-23-1980
Closed
Phase
SWOG Clinical Trial Number
SWOG-7940/43
Evaluation of Gallium Nitrate in Metastatic Adenocarcinoma of the Large Bowel
Activated
02-27-1980
Closed
09-23-1980